There is no question that loss or mutation of crucial genes are frequent events in cancer biology: the mutation of the tumor suppressor gene p53 is observed in almost 50% of human cancers1–7, and the amplification of the oncogene MYC8 or the translocation of BCL-2 gene9–12 are crucial drivers in various cancer contexts13–16. The gene discussed is BCL2; the disease is cancer.